Loading insider details...
Beta
Latest Form 4 (Jul 1, 2026): Disposition to Issuer of 613,252 APTO shares, $1.05M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 1, 2026 | Aptose Biosciences Inc. (APTO) | Disposition to Issuer | 613,252 | $1.05M |
| Nov 26, 2024 | Aptose Biosciences Inc. (APTO) | Purchase | 100,000 | $20.0K |
| Feb 7, 2024 | Aptose Biosciences Inc. (APTO) | Grant/Award | 70,000 | n/a |
| Jan 24, 2023 | Aptose Biosciences Inc. (APTO) | Grant/Award | 150,000 | n/a |
| Sep 21, 2022 | Aptose Biosciences Inc. (APTO) | Purchase | 10,000 | $6.8K |
| Jul 7, 2022 | Aptose Biosciences Inc. (APTO) | Grant/Award | 600,000 | n/a |
| Jun 6, 2022 | Aptose Biosciences Inc. (APTO) | Purchase | 10,000 | $9.7K |
| Jan 20, 2022 | Aptose Biosciences Inc. (APTO) | Grant/Award | 700,000 | n/a |
| Dec 17, 2021 | Aptose Biosciences Inc. (APTO) | Purchase | 13,183 | $20.0K |
| Dec 15, 2021 | Aptose Biosciences Inc. (APTO) | Purchase | 17,822 | $20.0K |